期刊文献+

子宫内膜样腺癌中MDM2、EZH2和RUNX3的表达及其相关性 被引量:7

Expression of MDM2,EZH2 and RUNX3 and their relationship in endometrial adenocarcinomas
下载PDF
导出
摘要 目的探讨MDM2、EZH2和RUNX3在正常子宫内膜、子宫内膜增殖症和子宫内膜样腺癌(endometrioid adenocarcinoma,EA)组织中的表达及其相关性。方法采用组织芯片技术和免疫组化SP法检测30例正常子宫内膜组织、30例单纯性增生内膜、30例复杂伴不典型性增生内膜、72例EA组织中MDM2、EZH2和RUNX3蛋白表达。结果 MDM2、EZH2和RUNX3蛋白在EA组织中的阳性表达率分别是80.6%(58/72)、83.3%(60/72)、26.4%(19/72),MDM2和EZH2阳性率明显高于正常和各型增生内膜(P均<0.05);而RUNX3的阳性表达率明显低于正常和单纯性增生子宫内膜(P<0.01)。MDM2过表达与组织学分级、临床分期、肌层浸润深度和淋巴结转移均无关;EZH2和RUNX3阳性表达与组织学分级、临床分期和肌层浸润深度均有关(P均<0.05),与淋巴结转移均无关。EZH2与RUNX3蛋白表达呈负相关(rs=-0.262,P<0.05)。结论 MDM2、EZH2和RUNX3蛋白表达异常可能与EA的发生、发展密切相关,有望作为反映EA生物学行为及预后的重要标记物。 Purpose To investigate the relationship of the expression of MDM2,EZH2 and RUNX3 protein in the pathologenesis of endometrial carcinoma.Methods The expression levels of MDM2,EZH2 and RUNX3 proteins in endometrial adenocarcinomas tissues(n=72),endometrial hyperplasia tissues(n=60) and normal tissues(n=30) were examined by tissue microarray technique and immunohistochemistry(SP method).Results The positive expression rates of MDM2,EZH2 and RUNX3 protein in endometrial adenocarcinomas were 80.6%(58/72),83.3%(60/72) and 26.4%(19/72),respectively.The positive rates of both MDM2 and EZH2 protein in endometrial carcinomas were higher than that in normal endometrium and endometrial hyperplasia(P0.05);but the positive rate of RUNX3 in endometrial carcinomas was lower than that in normal and simple hyperplasia endometrium(P0.01).The positive expression of MDM2 was not related to the histological grade,FIGO stage,depth of invasion and lymph node metastasis.The positive expression of EZH2 and RUNX3 was related to histological grade,FIGO stage,depth of invasion(P0.05),but it was not related to the lymph node metastasis.The expression of EZH2 protein was negatively related to that of RUNX3(rs=-0.262,P0.05).Conclusion The abnormal expression of MDM2,EZH2 and RUNX3 protein is associated with the pathogenesis and progression of endometrioid adenocarcinoma,which are expected to serve as important biomarkers to reflect the biological behaviors and prognosis in endometrial adenocarcinoma.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2010年第6期688-692,共5页 Chinese Journal of Clinical and Experimental Pathology
基金 安徽省卫生厅医学科研项目(2010B010)
关键词 子宫肿瘤 腺癌 MDM2 EZH2 RUNX3 uterine neoplasms adenocarcinoma MDM2 EZH2 RUNX3
  • 相关文献

参考文献11

  • 1Lahav G,Rosenfeld N,Sigal A,et al.Dynamics of the p53-Mdm2 feedback loop in individual cells[J].Nat Genet,2004,36(2):147-50. 被引量:1
  • 2Morgan R J,Newcomb P V,Hardwick R H,et al.Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma[J].Eur J Surg Oncol,1999,25(4):364-7. 被引量:1
  • 3赵秀芝,刘东满,王立群,史玮琪.mdm2在子宫内膜癌组织中的表达及意义[J].山东医药,2009,49(15):47-47. 被引量:2
  • 4Kuzmichev A,Jenuwein T,Tempst P,et al.Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3[J].Mol Cell,2004,14(2):183-93. 被引量:1
  • 5Tang X,Milyavsky M,Shats I,et al.Activated p53 suppresses the histone methyltransferase EZH2 gene[J].Oncogene,2004,23(34):5759-69. 被引量:1
  • 6李全香,刘君,王志芳,贾云昀.EZH2在子宫内膜癌中表达的意义[J].中国妇幼保健,2009,24(10):1403-1406. 被引量:6
  • 7Fukamachi H.Runx3 controls growth and differentiation of gastric epithelial cells in mammals[J].Dev Growth Differ,2006,48(1):1-l3. 被引量:1
  • 8Zaidi S K,Sullivan A J,van Wijnen A J,et al.Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites[J].Proc Natl Acad Sei USA,2002,99(12):8048-53. 被引量:1
  • 9Yoshizaki T,Enomoto T,Fujita M,et al.Frequent inactivation of RUNX3 in endometrial carcinoma[J].Gynecologic Oncology,2008,(110):439-44. 被引量:1
  • 10Fujii S,Ito K,Ito Y,et al.Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation[J].J Biol Chem,2008,283(25):17324-32. 被引量:1

二级参考文献16

  • 1Hanson RD, Hess JL, Yu BD et al. Mammalian Trithorax and Polycomb - group homo logues are antagonistic regulators of homeotic development [J] .PNAS, 1999, 25 (96): 14372 被引量:1
  • 2Julie L, Gu S. Polycomb group genes as epigenetic regulators of normal and leukemic h emopoiesis [J] . J Ex Hematol, 2003, 3:567 被引量:1
  • 3Tonini T, Bagella L, Andrilli G et al. Ezh2 reduces the ability of HDAC1 -dependent pRb2/p130 transcriptional repression of cyclin [J]. Oncogene, 2004, 23 (28): 4930 被引量:1
  • 4Bracken AP, Pasini D, Capra M et al. EZH2 is down stream of the pRB -E2F pathway, essential for proliferation and amplified in cancer [J].EMBO, 2003, 22 (20): 5323 被引量:1
  • 5Ingeborg M, Bachmann, Ole J Halvorsen et al. EZH2 Expresion is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate and breast [J] . Journal of clinical oncology, 2006, 2 (24) : 268 被引量:1
  • 6Jacobs J L, van Lohuizen M. Pol combre ression : from cellular rolifeation and cancer [ J] . J Biochim Biophys Acta, 2002, 1602:151 被引量:1
  • 7Carlos Cardoso, Cecile Minon, Gilles Hetet et al. The human EZH2 gene: genomic or anisatin and revised mapping in7q35 within the critical reion for maligment myeloid disorders [J] . Eur J Hum Genetics,2000, 8:174 被引量:1
  • 8Varambally S, Dhanasekaran SM, Ming H et al. The poly - comb group protein EZH2 is involved in progression of prostate cancer [J] . Nature, 2002, 419:624 被引量:1
  • 9Raaphorst FM, Meijer C J, Fieret E et al. poorly differentiated breast carcinoma is associated with increased expressionof the human polycomb group EZH2 gene [J]. Neoplasia, 2003, 5 (6): 481 被引量:1
  • 10Meltzer PS. MDM2 and p53 :a question of balance[J]. J Natl Cancer Inst, 1994,86 (5) : 1265. 被引量:1

共引文献6

同被引文献125

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部